Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Evrenzo (roxadustat)
Pharma
FibroGen, Kind Pharma settle trade secrets theft dispute
After FibroGen accused two former scientists of trade secrets theft, both the plaintiffs and the defendants have walked away from the lawsuit.
Fraiser Kansteiner
Apr 19, 2024 12:53pm
BeiGene, BMS, AZ-FibroGen and more—Fierce Pharma Asia
Mar 1, 2024 8:55am
AstraZeneca finally drops roxadustat US rights
Feb 27, 2024 11:28am
FibroGen CEO Enrique Conterno hits the exit after 3-year stint
Jul 25, 2023 2:02pm
Astellas' new CEO takes over a company in transition
Jun 13, 2023 8:50am
Takeda, AstraZeneca, Astellas and more—Fierce Pharma Asia
May 19, 2023 9:25am
